To include your compound in the COVID-19 Resource Center, submit it here.

Zambon, US WorldMeds deal

Zambon granted US WorldMeds exclusive, U.S. rights to market Parkinson’s disease drug Xadago safinamide. Zambon

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE